Veralto (NYSE:VLTO) Stock: Insider Bernard Skeete Sells 1,514 Shares

Veralto Corporation (NYSE:VLTO) CAO Bernard Skeete sold 1,514 shares of the stock in a transaction that occurred on Monday, November 2nd. The shares were sold at an average price of $112.58, for a total value of $170,446.12. Following the completion of the sale, the chief accounting officer directly owned 4,760 shares of the company’s stock, valued at approximately $535,880.80. This represents a 24.13% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Veralto Stock Down 0.3%

NYSE VLTO opened at $116.66 on Friday. Veralto Corporation has a 52 week low of $80.03 and a 52 week high of $119.03. The firm has a market cap of $28.36 billion, a PE ratio of 28.88, a P/E/G ratio of 3.24 and a beta of 0.51. The business’s fifty day simple moving average is $99.63 and its 200-day simple moving average is $93.41. The company has a quick ratio of 1.61, a current ratio of 2.03 and a debt-to-equity ratio of 0.83.

Veralto (NYSE:VLTO) last posted its earnings results on Thursday, October 29th. The company reported $1.18 earnings per share for the quarter, beating the consensus estimate of $1.09 by $0.09. Veralto had a net margin of 17.27% and a return on equity of 35.08%. The company had revenue of $1.51 billion for the quarter, compared to analyst estimates of $1.50 billion. During the same period in the previous year, the business posted $0.99 EPS. Veralto’s revenue was up 7.5% on a year-over-year basis. As a group, equities analysts anticipate that Veralto Corporation will post 4.51 earnings per share for the current year.

Veralto Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 30th. Investors of record on Wednesday, September 30th were issued a $0.13 dividend. This represents a $0.52 annualized dividend and a yield of 0.4%. The ex-dividend date was Wednesday, September 30th. Veralto’s payout ratio is 12.87%.

Analyst Ratings Changes

Several equities analysts recently issued reports on VLTO shares. Barclays increased their target price on Veralto from $117.00 to $129.00 and gave the stock an “overweight” rating in a research note on Monday. Citigroup lifted their price objective on Veralto from $107.00 to $120.00 and gave the company a “neutral” rating in a research note on Monday. UBS Group boosted their price objective on Veralto from $104.00 to $106.00 and gave the stock a “neutral” rating in a research report on Monday, October 5th. Royal Bank Of Canada raised their price objective on shares of Veralto from $109.00 to $121.00 and gave the company a “sector perform” rating in a report on Monday. Finally, Wall Street Zen lowered Veralto from a “buy” rating to a “hold” rating in a research report on Saturday, October 24th. Seven research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, Veralto presently has an average rating of “Moderate Buy” and a consensus price target of $120.70.

Key Stories Impacting Veralto

Here are the key news stories impacting Veralto this week:

• Positive Sentiment: Barclays reiterated its Buy-equivalent Overweight rating and raised its price target to $129 from $117, indicating potential upside in the firm’s view. Barclays rating
• Positive Sentiment: Veralto’s latest reported quarter beat analyst expectations for earnings and revenue: EPS was $1.18 versus $1.09 expected, while revenue reached $1.51 billion and grew 7.5% year over year. Quarterly results
• Neutral Sentiment: Citigroup and RBC also raised their price targets, to $120 and $121, respectively, but kept neutral or sector-perform ratings—more cautious than Barclays. Citigroup rating RBC rating
• Negative Sentiment: Multiple executives reported selling shares: SVP Mattias Byström sold 9,069 shares, CAO Bernard Skeete sold 1,514, and SVP Surekha Trivedi sold 36,427, reducing her holdings by about 81%. Trivedi’s sale was made under a pre-arranged trading plan; insider sales can nevertheless weigh on sentiment. Byström filing Skeete filing Trivedi filing

Institutional Trading of Veralto

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. MGO One Seven LLC raised its holdings in shares of Veralto by 3.2% in the third quarter. MGO One Seven LLC now owns 3,477 shares of the company’s stock worth $328,000 after acquiring an additional 107 shares during the last quarter. Valeo Financial Advisors LLC lifted its stake in shares of Veralto by 5.0% during the 2nd quarter. Valeo Financial Advisors LLC now owns 2,751 shares of the company’s stock worth $244,000 after purchasing an additional 131 shares during the period. Quadrant Capital Group LLC boosted its holdings in shares of Veralto by 1.2% during the third quarter. Quadrant Capital Group LLC now owns 12,100 shares of the company’s stock worth $1,198,000 after purchasing an additional 141 shares during the last quarter. Nolet Wealth Management LLC boosted its holdings in shares of Veralto by 1.0% during the second quarter. Nolet Wealth Management LLC now owns 15,277 shares of the company’s stock worth $1,355,000 after purchasing an additional 146 shares during the last quarter. Finally, North Dakota State Investment Board boosted its holdings in shares of Veralto by 2.0% during the third quarter. North Dakota State Investment Board now owns 7,517 shares of the company’s stock worth $709,000 after purchasing an additional 150 shares during the last quarter. 91.28% of the stock is owned by hedge funds and other institutional investors.

Veralto Company Profile

Veralto Corporation (NYSE: VLTO) is a global provider of technology, products and services that help customers manage water quality and improve the quality, safety and efficiency of packaged goods. The company serves municipal, industrial, commercial and consumer-facing markets through a portfolio of operating businesses.

Veralto’s Water Quality segment provides instruments, software and services used to test, monitor and treat water and wastewater. Its brands include Hach, Trojan Technologies and ChemTreat, which support applications such as laboratory and field testing, disinfection, water treatment and industrial water management.

The company’s Product Quality & Innovation segment supplies technologies used in product identification, packaging design, color management and quality inspection.